
|Articles|April 24, 2008
Vyvanse approved to treat adults with ADHD
Shire plc's Vyvanse can now be treated not only among children but also adults.
Advertisement
Approved in July 2007 to treat attention deficit hyperactivity disorder (ADHD) in kids six to 12 years of age, Shire plc's
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























